ArticleEndocrine2021

The validity of cost-effectiveness analyses of tight glycemic control. A systematic survey of economic evaluations of pharmacological interventions in patients with type 2 diabetes.

Francisco J Barrera et al.PubMed ↗Publisher ↗

No numbers read from the abstract.